Cite
Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment
MLA
Guan-hua Hu, et al. “Allogeneic Hematopoietic Stem Cell Transplantation Can Improve the Prognosis of High-Risk Pediatric t(8;21) Acute Myeloid Leukemia in First Remission Based on MRD-Guided Treatment.” BMC Cancer, vol. 20, no. 1, June 2020, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12885-020-07043-5.
APA
Guan-hua Hu, Yi-fei Cheng, Ai-dong Lu, Yu Wang, Ying-xi Zuo, Chen-hua Yan, Jun Wu, Yu-qian Sun, Pan Suo, Yu-hong Chen, Huan Chen, Yue-ping Jia, Kai-yan Liu, Wei Han, Lan-ping Xu, Le-ping Zhang, & Xiao-jun Huang. (2020). Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment. BMC Cancer, 20(1), 1–8. https://doi.org/10.1186/s12885-020-07043-5
Chicago
Guan-hua Hu, Yi-fei Cheng, Ai-dong Lu, Yu Wang, Ying-xi Zuo, Chen-hua Yan, Jun Wu, et al. 2020. “Allogeneic Hematopoietic Stem Cell Transplantation Can Improve the Prognosis of High-Risk Pediatric t(8;21) Acute Myeloid Leukemia in First Remission Based on MRD-Guided Treatment.” BMC Cancer 20 (1): 1–8. doi:10.1186/s12885-020-07043-5.